Non-invasive diagnosis and disease staging of NAFLD
Prof. Manuel Castro Cabezas
Manuel is a senior consultant for endocrinology, internal medicine, and vascular diseases at the Franciscus Gasthuis Rotterdam and associate professor of medicine at Erasmus Medical Center, Rotterdam, the Netherlands.
Prof. dr. Christophe Moreno, M.D.
Christophe is a professor in gastroenterology and hepatology and clinical director of the liver unit at CUB Hôpital Erasme, Brussels, Belgium. He is an important consultant to the NASH Clinical team.
Given the high prevalence of NAFLD in the general population, identifying the persons at a high risk for development of cirrhosis is key. During this presentation, Professor Hannes Hagström focussed on methods and strategies to achieve this in different settings.
Speaker: Prof. Hannes Hagström
Host: Dr. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
Upcoming webinar: Why NASH trials frequently fail and how to improve them
The upcoming NASH clinical webinar promises to be an insightful and informative session, with our scientific officer Manuel Castro Cabezas as the guest speaker. Manuel will be sharing his expertise on the topic of "Why NASH trials frequently fa...
Getting GRIP on NASH: Implementation of an international screening program
During the 5th Global NASH Congress in London, Our Chief Scientific Officer Prof. Dr. D.E. Grobbee was one of the speakers and presented: Getting GRIP on NASH; Implementation of an International Clinical Screening Program. During this presentat...
NAFLD: patient identification strategies
In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...